New treatment options, such as ceftazidime/avibactam, meropenem/vaborbactam, ceftolozane/tazobactam, plazomicin, and eravacycline have become available.

Several antibiotics have been approved for the treatment of gram-negative bacterial infections, and clinical trials are underway that promise to provide ...

Ceftolozane-tazobactam represents a good option for the treatment of susceptible MDR/XDR Pseudomonas aeruginosa infections, and it may be a first-line option in ...

For patients who are critically ill and/or experiencing hypoalbuminemia, meropenem or imipenem-cilastatin are the preferred carbapenems.

11 апр. 2024 г. · Treatment. Gram-negative infections can be difficult to treat. Some types of gram-negative bacteria can become resistant to multiple drugs, ...

1 июл. 2012 г. · For infections with Gram-negative bacteria, antimicrobial synergy has traditionally been seen with β-lactam–aminoglycoside combinations. The ...

There is evidence supporting the initial use of combina- tion therapy for severe infections with Gram-negative bacteria, such as sepsis or ventilator-associated ...

There are a number of oral and parenteral antimycoplasmid therapies, including enrofloxacin, tylosin, doxycycline, or clarithromycin. Flushing the nasal cavity ...

27 авг. 2022 г. · Aztreonam/Avibactam Since 1986, aztreonam has been the only monobactam antimicrobial licensed to treat gram-negative infections. Ambler class A ...

In this review, we provide an overview of antibiotics newly approved for the treatment of pneumonia caused by Gram-negative bacilli.